NYSE · Medical - Diagnostics & Research

Danaher Corporation (DHR) Stock

$219.87 +1.11% NYSE: DHR Healthcare

Valuation

MetricValue
Price$219.87
Market Cap$154.57B
P/E Ratio39.76
P/B Ratio3.01
P/S Ratio6.29
EPS (TTM)$5.04
52-Week High$242.80
52-Week Low$160.93
Dividend Yield0.71%

Financials & Margins

MetricValue
ROE7.66%
ROA4.33%
ROCE6.08%
Gross Margin20.91%
Operating Margin20.91%
Net Margin15.95%
Debt/Equity0.51
Current Ratio1.87

Annual Financials (USD)

Metric20212022202320242025
Revenue$29.5B$26.6B$23.9B$23.9B$24.6B
Operating Profit$8.1B$7.5B$5.3B$5.2B$5.1B
Net Profit$6.4B$7.2B$4.8B$3.9B$3.6B
EPS$8.61$9.64$6.38$5.29$5.04
Op Margin27.3%28.3%22.1%21.7%20.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$83.2B$84.3B$84.5B$77.5B$83.5B
Total Liabilities$38.0B$34.3B$31.0B$28.0B$30.9B
Cash$2.6B$6.0B$5.9B$2.1B$4.6B
Borrowings$23.3B$20.6B$19.5B$17.1B$18.4B

Latest News

Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating MT Newswires · Jul 13, 2026 OmniAb Names Amechi Nwachuku Chief Operating Officer Business Wire · Jul 13, 2026 Cell Isolation Market/Cell Separation Market by Product, Cell Type, Source, Technique, Application, End User, Competition, Region - Global Forecast to 2031 GlobeNewswire · Jul 13, 2026 Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment 24/7 Wall St. · Jul 10, 2026 Jim Cramer on Danaher: “I Don’t Want You Anywhere Near That One” Insider Monkey · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$8.4B$8.5B$7.2B$6.7B$6.4B
Investing Cash Flow$-14.3B$-3.4B$-8.5B$-3.4B$-2.4B
Financing Cash Flow$-16.0M$-95.0M$2.1B$-6.1B$-3.2B
Net Cash Flow$-3.4B$3.4B$-131.0M$-3.8B$2.5B
Free Cash Flow$7.1B$7.4B$5.8B$5.3B$5.3B

Valuation & Return Ratios

MetricValue
PEG Ratio2.04
EV / EBITDA25.19
FCF Yield3.46%
Quick Ratio1.25
Interest Coverage65.73
Return 1Y8.29%
Return 3Y2.41%
Return 5Y-17.55%

Ownership

Insiders Held10.74%
Institutions Held84.49%
Institutions Float Held94.65%
Institutional HolderSharesReport Date
Blackrock Inc.51,640,6192026-03-31
Vanguard Capital Management LLC41,127,8102026-03-31
State Street Corporation27,894,1812026-03-31
FMR, LLC22,534,3292026-03-31
JPMORGAN CHASE & CO16,917,6492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAgilent Technologies, Inc. $170.54 +1.41% 33.95 $48.17B 0.59%
BMXXYbioMérieux S.A. $7.60 -5.35% 21.32 $8.96B 1.45%
BRKRBruker Corporation $58.84 +1.59% -91.36 $8.96B 0.31%
ILMNIllumina, Inc. $278.17 +5.14% 49.91 $42.09B 0.00%
MTDMettler-Toledo International, Inc. $1549.99 +1.34% 31.26 $31.32B 0.00%

About Danaher Corporation

Danaher Corporation is led by CEO Rainer Blair, employs 61,000 people, headquartered in Washington, US, publicly traded since 1978.

Danaher Corporation (DHR) stock trades at $219.87 with a market capitalization of $154.57B. The stock is valued at a price-to-earnings (P/E) ratio of 39.76, price-to-book of 3.01, price-to-sales of 6.29. Over the past 52 weeks the stock has ranged between $160.93 and $242.80, and currently trades 9.4% below its 52-week high. It pays a dividend yielding 0.71%.

On profitability, Danaher Corporation generates a return on equity (ROE) of 7.66%, return on capital employed of 6.08%, an operating margin of 20.91%, a net profit margin of 15.95%.

In its most recent fiscal year, Danaher Corporation reported annual revenue of $24.6B, net profit of $3.6B, revenue has compounded at 2.0% a year over the last five years, profit at -0.2% a year.

The balance sheet shows a debt-to-equity ratio of 0.51, a current ratio of 1.87, total assets of $83.5B, $4.6B in cash and equivalents.

DHR has a beta of 0.81.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides